Cargando…

Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?

Detalles Bibliográficos
Autores principales:	Kassi, Eva N., Papavassiliou, Kostas A., Papavassiliou, Athanasios G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IMSS. Published by Elsevier Inc. 2020
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242954/ https://www.ncbi.nlm.nih.gov/pubmed/32471702 http://dx.doi.org/10.1016/j.arcmed.2020.05.017

Ejemplares similares

The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2?
por: Kassi, Eva N., et al.
Publicado: (2020)

Could glucose be a proaging factor?
por: Kassi, Eva, et al.
Publicado: (2008)

Glucose can promote a glucocorticoid resistance state
por: Kassi, Eva, et al.
Publicado: (2012)

Lung Cancer through Transcription Factors
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Malignant circuits: Novel therapeutic opportunities in neuro‐oncology
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

Vitamin D affects glucocorticoid action in target cells
por: Kassi, Eva, et al.
Publicado: (2016)

Targeting STAT3 Signaling Pathway in Colorectal Cancer
por: Gargalionis, Antonios N., et al.
Publicado: (2021)

Polycystins, mechanotransduction and cancer development
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

Targeting the YAP/TAZ mechanotransducers in solid tumour therapeutics
por: Gargalionis, Antonios N., et al.
Publicado: (2023)

Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives
por: Gargalionis, Antonios N., et al.
Publicado: (2023)

Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
por: Piperi, Christina, et al.
Publicado: (2019)

Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks
por: Stravopodis, Dimitrios J., et al.
Publicado: (2023)

mTOR Signaling Components in Tumor Mechanobiology
por: Gargalionis, Antonios N., et al.
Publicado: (2022)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
por: Sarantis, Panagiotis, et al.
Publicado: (2022)

Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity
por: Markouli, Mariam, et al.
Publicado: (2021)

Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis
por: Markouli, Mariam, et al.
Publicado: (2022)

Polycystin‐1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro
por: Zoi, Ilianna, et al.
Publicado: (2022)

A set of sum rules for anomalous gauge boson couplings
por: Papavassiliou, Joannis, et al.
Publicado: (1998)

Probing the $WW \gamma$ vertex at hadron colliders
por: Papavassiliou, Joannis, et al.
Publicado: (1999)

Singular lensing from the scattering on special space–time defects
por: Mavromatos, Nick E., et al.
Publicado: (2018)

Polycystin‐1 modulates RUNX2 activation and osteocalcin gene expression via ERK signalling in a human craniosynostosis cell model
por: Katsianou, Maira, et al.
Publicado: (2021)

Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments
por: Pneumaticos, Spyros G, et al.
Publicado: (2010)

Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review
por: Nasiri-Ansari, Narjes, et al.
Publicado: (2022)

Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Complexity in cancer biology: is systems biology the answer?
por: Koutsogiannouli, Evangelia, et al.
Publicado: (2013)

The glucocorticoid receptor signalling in breast cancer
por: Moutsatsou, Paraskevi, et al.
Publicado: (2008)

Polycystin‐1 regulates cell proliferation and migration through AKT/mTORC2 pathway in a human craniosynostosis cell model
por: Katsianou, Maria A., et al.
Publicado: (2022)

Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability
por: Nasiri-Ansari, Narjes, et al.
Publicado: (2022)

COVID-19 pandemic: Is it the right time to develop interconnected national biomedical registries?
por: Kotoulas, Athanasios S.
Publicado: (2021)

The Multifaceted Output of c-Jun Biological Activity: Focus at the Junction of CD8 T Cell Activation and Exhaustion
por: Papavassiliou, Athanasios G., et al.
Publicado: (2020)

A systems approach identifies co-signaling molecules of early growth response 1 transcription factor in immobilization stress
por: Papanikolaou, Nikolaos A, et al.
Publicado: (2014)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020)

Polycystin‐1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines
por: Papavassiliou, Kostas A., et al.
Publicado: (2019)

Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
por: Nasiri-Ansari, Νarjes, et al.
Publicado: (2018)

Orexin-A Exerts Equivocal Role in Atherosclerosis Process Depending on the Duration of Exposure: In Vitro Study
por: Nasiri Ansari, Narjes, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4meh5gjuog8prk4rrf2uvfv5hc